Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade

Hiroshi Yamaguchi, Takahiro Inoue, Takashi Eguchi, Yoshihiro Miyasaka, Kenoki Ouchida, Kazuhiro Mizumoto, Tomomi Yamada, Koji Yamaguchi, Masao Tanaka, Masazumi Tsuneyoshi

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Intraductal papillary mucinous neoplasm (IPMN) is a well-established entity in pancreatic neoplasms and a precursor of infiltrating adenocarcinoma. Fascin, an actin-bundling protein involved in cellular motility, is upregulated in many human neoplasms. Its overexpression in pancreatic intraepithelial neoplasia, a pre-cancerous lesion sharing many characteristics with IPMN, has been reported. However, fascin expression in IPMN remains unknown. The aim of this study was to investigate fascin expression in IPMNs and to elucidate its relationship to clinicopathological features, including histological grade and phenotypic subclassification. We evaluated fascin expression by immunohistochemistry in 116 surgical specimens, followed by quantitative analysis of fascin mRNA expression using a laser microdissection system and real-time reverse-transcriptase polymerase chain reaction in eight frozen samples. Fascin expression was significantly higher in borderline neoplasms (25/29, 86%) and carcinomas (37/42, 88%) than in adenomas (23/45, 51%) (P<0.05, respectively), but no difference was observed between borderline neoplasms and carcinomas. With regard to the subclassification, intestinal-type neoplasms (35/39, 90%) were more frequently positive for fascin than gastric-type neoplasms (36/59, 61%) (P<0.05). Two oncocytic-type neoplasms were both fascin-negative. Fascin mRNA expression seemed to be higher in moderately to severely dysplastic epithelium than in mildly dysplastic epithelium (not statistically significant), supporting the immunohistochemical experiments. Our findings suggest that fascin overexpression is involved in the progression of IPMN. Fascin could become a new therapeutic target for inhibition of their progression.

Original languageEnglish
Pages (from-to)552-561
Number of pages10
JournalModern Pathology
Volume20
Issue number5
DOIs
Publication statusPublished - May 30 2007

Fingerprint

Pancreatic Neoplasms
Adenoma
Carcinoma
Neoplasms
fascin
Epithelium
Intestinal Neoplasms
Microdissection
Messenger RNA
Reverse Transcriptase Polymerase Chain Reaction
Stomach Neoplasms
Actins
Real-Time Polymerase Chain Reaction
Adenocarcinoma
Lasers
Immunohistochemistry

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade. / Yamaguchi, Hiroshi; Inoue, Takahiro; Eguchi, Takashi; Miyasaka, Yoshihiro; Ouchida, Kenoki; Mizumoto, Kazuhiro; Yamada, Tomomi; Yamaguchi, Koji; Tanaka, Masao; Tsuneyoshi, Masazumi.

In: Modern Pathology, Vol. 20, No. 5, 30.05.2007, p. 552-561.

Research output: Contribution to journalArticle

Yamaguchi, Hiroshi ; Inoue, Takahiro ; Eguchi, Takashi ; Miyasaka, Yoshihiro ; Ouchida, Kenoki ; Mizumoto, Kazuhiro ; Yamada, Tomomi ; Yamaguchi, Koji ; Tanaka, Masao ; Tsuneyoshi, Masazumi. / Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade. In: Modern Pathology. 2007 ; Vol. 20, No. 5. pp. 552-561.
@article{a31dfc3cbffc4d03a643a1b480629ddc,
title = "Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade",
abstract = "Intraductal papillary mucinous neoplasm (IPMN) is a well-established entity in pancreatic neoplasms and a precursor of infiltrating adenocarcinoma. Fascin, an actin-bundling protein involved in cellular motility, is upregulated in many human neoplasms. Its overexpression in pancreatic intraepithelial neoplasia, a pre-cancerous lesion sharing many characteristics with IPMN, has been reported. However, fascin expression in IPMN remains unknown. The aim of this study was to investigate fascin expression in IPMNs and to elucidate its relationship to clinicopathological features, including histological grade and phenotypic subclassification. We evaluated fascin expression by immunohistochemistry in 116 surgical specimens, followed by quantitative analysis of fascin mRNA expression using a laser microdissection system and real-time reverse-transcriptase polymerase chain reaction in eight frozen samples. Fascin expression was significantly higher in borderline neoplasms (25/29, 86{\%}) and carcinomas (37/42, 88{\%}) than in adenomas (23/45, 51{\%}) (P<0.05, respectively), but no difference was observed between borderline neoplasms and carcinomas. With regard to the subclassification, intestinal-type neoplasms (35/39, 90{\%}) were more frequently positive for fascin than gastric-type neoplasms (36/59, 61{\%}) (P<0.05). Two oncocytic-type neoplasms were both fascin-negative. Fascin mRNA expression seemed to be higher in moderately to severely dysplastic epithelium than in mildly dysplastic epithelium (not statistically significant), supporting the immunohistochemical experiments. Our findings suggest that fascin overexpression is involved in the progression of IPMN. Fascin could become a new therapeutic target for inhibition of their progression.",
author = "Hiroshi Yamaguchi and Takahiro Inoue and Takashi Eguchi and Yoshihiro Miyasaka and Kenoki Ouchida and Kazuhiro Mizumoto and Tomomi Yamada and Koji Yamaguchi and Masao Tanaka and Masazumi Tsuneyoshi",
year = "2007",
month = "5",
day = "30",
doi = "10.1038/modpathol.3800763",
language = "English",
volume = "20",
pages = "552--561",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade

AU - Yamaguchi, Hiroshi

AU - Inoue, Takahiro

AU - Eguchi, Takashi

AU - Miyasaka, Yoshihiro

AU - Ouchida, Kenoki

AU - Mizumoto, Kazuhiro

AU - Yamada, Tomomi

AU - Yamaguchi, Koji

AU - Tanaka, Masao

AU - Tsuneyoshi, Masazumi

PY - 2007/5/30

Y1 - 2007/5/30

N2 - Intraductal papillary mucinous neoplasm (IPMN) is a well-established entity in pancreatic neoplasms and a precursor of infiltrating adenocarcinoma. Fascin, an actin-bundling protein involved in cellular motility, is upregulated in many human neoplasms. Its overexpression in pancreatic intraepithelial neoplasia, a pre-cancerous lesion sharing many characteristics with IPMN, has been reported. However, fascin expression in IPMN remains unknown. The aim of this study was to investigate fascin expression in IPMNs and to elucidate its relationship to clinicopathological features, including histological grade and phenotypic subclassification. We evaluated fascin expression by immunohistochemistry in 116 surgical specimens, followed by quantitative analysis of fascin mRNA expression using a laser microdissection system and real-time reverse-transcriptase polymerase chain reaction in eight frozen samples. Fascin expression was significantly higher in borderline neoplasms (25/29, 86%) and carcinomas (37/42, 88%) than in adenomas (23/45, 51%) (P<0.05, respectively), but no difference was observed between borderline neoplasms and carcinomas. With regard to the subclassification, intestinal-type neoplasms (35/39, 90%) were more frequently positive for fascin than gastric-type neoplasms (36/59, 61%) (P<0.05). Two oncocytic-type neoplasms were both fascin-negative. Fascin mRNA expression seemed to be higher in moderately to severely dysplastic epithelium than in mildly dysplastic epithelium (not statistically significant), supporting the immunohistochemical experiments. Our findings suggest that fascin overexpression is involved in the progression of IPMN. Fascin could become a new therapeutic target for inhibition of their progression.

AB - Intraductal papillary mucinous neoplasm (IPMN) is a well-established entity in pancreatic neoplasms and a precursor of infiltrating adenocarcinoma. Fascin, an actin-bundling protein involved in cellular motility, is upregulated in many human neoplasms. Its overexpression in pancreatic intraepithelial neoplasia, a pre-cancerous lesion sharing many characteristics with IPMN, has been reported. However, fascin expression in IPMN remains unknown. The aim of this study was to investigate fascin expression in IPMNs and to elucidate its relationship to clinicopathological features, including histological grade and phenotypic subclassification. We evaluated fascin expression by immunohistochemistry in 116 surgical specimens, followed by quantitative analysis of fascin mRNA expression using a laser microdissection system and real-time reverse-transcriptase polymerase chain reaction in eight frozen samples. Fascin expression was significantly higher in borderline neoplasms (25/29, 86%) and carcinomas (37/42, 88%) than in adenomas (23/45, 51%) (P<0.05, respectively), but no difference was observed between borderline neoplasms and carcinomas. With regard to the subclassification, intestinal-type neoplasms (35/39, 90%) were more frequently positive for fascin than gastric-type neoplasms (36/59, 61%) (P<0.05). Two oncocytic-type neoplasms were both fascin-negative. Fascin mRNA expression seemed to be higher in moderately to severely dysplastic epithelium than in mildly dysplastic epithelium (not statistically significant), supporting the immunohistochemical experiments. Our findings suggest that fascin overexpression is involved in the progression of IPMN. Fascin could become a new therapeutic target for inhibition of their progression.

UR - http://www.scopus.com/inward/record.url?scp=34247328661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247328661&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3800763

DO - 10.1038/modpathol.3800763

M3 - Article

VL - 20

SP - 552

EP - 561

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 5

ER -